Ligand Pharma (LGND) Reports Mixed Q4 Results; FY11 Revs Guidance Light

February 15, 2011 8:10 AM

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) reported Q4 EPS of $0.12 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found